Analysts Set Guardant Health, Inc. (NASDAQ:GH) Price Target at $49.20

Guardant Health, Inc. (NASDAQ:GH – Get Free Report) has been assigned an average rating of “Moderate Buy” from the sixteen research firms that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold recommendation and fifteen have assigned a buy recommendation to the company. The average 12-month price target […]

Related Keywords

United States ,Sanfordc Bernstein ,Kumud Kalia ,Piper Sandler ,Raymond James ,William Blair ,Guardant Health Inc ,Analyst Recommendations For Guardant Health ,First Foundation Advisors ,Securities Exchange Commission ,Manufacturers Life Insurance Company ,Nasdaq ,Guardant Health ,Insider Transactions At Guardant Health ,Institutional Trading Of Guardant Health ,Rock Asset Management ,News Ratings For Guardant Health Daily ,Guardant Health Stock Performance ,Goldman Sachs Group ,Get Free Report ,Exchange Commission ,Foundation Advisors ,Get Free ,Next Test ,Guardant Health Daily ,Nasdaq Gh ,Ugh ,Medical ,Ratings ,Consensus ,